Vancouver, British Columbia, November 07, 2025 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has granted a total of 831,356 restricted shares (“Rocket Doctor AI”).RSU“) and 20,964 stock options (“Options“) to consultants and employees of the Company and its subsidiary Rocket Doctor Inc.
Each option is exercisable for one common share of the Company at an exercise price of C$0.82 per share for a period of three years from the date of grant and is subject to vesting provisions. 325,000 EE is valid for a period of two years, and 506,356 EE for a period of three years. 203,000 RSUs vest immediately and 628,356 are subject to vesting conditions. All options and RSUs are subject to the terms of the Company's stock plans and applicable holding periods under the securities laws.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. offers physician-built AI-powered solutions designed to make high-quality healthcare accessible throughout the patient journey. The cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically proven decision support system developed with input from hundreds of physicians around the world.
Alongside GLM is Rocket Doctor Inc and its AI-powered digital health platform and marketplace. Our proprietary technology software and systems have helped more than 300 physicians provide care for more than 700,000 patient visits. Our proprietary technology software and systems enable physicians to independently launch and manage their own virtual or hybrid in-person practices, increasing efficiency, restoring physician autonomy, and expanding patient access to care.
By reducing administrative burden and providing greater continuity of care, our technology frees up more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural and remote communities in Canada that often lack access to family physicians and support for Medicaid and Medicare patients in the United States. With advanced artificial intelligence, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare to be more scalable, equitable, and patient-centric.
To learn more about Rocket Doctor AI Inc's products and services, contact:
www.rocketdoctor.ai or email: [email protected]
FOR MORE INFORMATION PLEASE CONTACT:
Dr. Essam Hamza, CEO of Rocket Doctor AI
[email protected]
Dr. Bill Cherniak, CEO of Rocket Doctor Inc.
[email protected]
For media inquiries please contact: [email protected]
Call: +1 (778) 819 8321
Cautionary Statements
This press release contains forward-looking statements regarding the future performance of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will,” “may,” “should,” “expect,” “expects” and similar expressions. All statements other than statements of historical fact included in this press release, including, without limitation, statements regarding the Offering, the use of proceeds from the Offering, the filing of the Prospectus Supplement and the future plans and objectives of Rocket Doctor AI Inc. are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks that are detailed from time to time in documents filed by Rocket Doctor AI Inc. to securities regulatory authorities.
The reader is cautioned that the assumptions used in preparing any forward-looking information may prove to be incorrect. Events or circumstances could cause actual results to differ materially from those projected due to numerous known and unknown risks, uncertainties and other factors, many of which are beyond Rocket Doctor AI Inc.'s control. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although believed to be reasonable by management at the time it was prepared, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. The forward-looking statements contained in this press release are made as of the date of this press release and Rocket Doctor AI Inc. will publicly update or revise the forward-looking statements included herein only as required by Canadian securities laws.
